Dr Reddy’s
Dr Reddy’s demand more than $70 million from Indivior over generic Suboxone Film
March 12, 2019Manufacturing and Production Dr Reddy's, Suboxone Film, court, indivior, opioid addiction
Indian firm Dr Reddy’s is seeking at least $70 million from British firm Indivior Plc as compensation for lost sales …
Indivior launches authorised generic version of opioid addiction treatment Suboxone as rival generic drugmakers enter market
February 21, 2019Sales and Marketing Alvogen, Dr Reddy's, Novartis, Sandoz, indivior
Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat …
Generics firms investigated for their involvement in the ‘largest cartel in the history of the United States’
December 11, 2018Manufacturing and Production Dr Reddy's, Mylan, Teva, US, corruption, generics, price fixing, price-fixing, sun
At least 16 generic drugmakers are being investigated for their involvement in what has been described as the “largest cartel …
Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute
June 18, 2018Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone
Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …
Dr Reddy’s hit by yet another recall, of 80,000+ bottles
February 8, 2018Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical
Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …
Top Ten most popular articles on Pharmafile.com this week
January 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate
As we come to the end of January, it’s Friday again – time for another rundown of the top ten …
Court fines Dr Reddy’s for improperly packaging products
January 22, 2018Sales and Marketing Dr Reddy's, biotech, drugs, pharma, pharmaceutical
On 18 December 2017, the District of New Jersey filed a complaint against Dr. Reddy’s Laboratories for failing to comply …
Dr Reddy’s gets greenlight to market Doxil generic
May 18, 2017Sales and Marketing Dr Reddy's, FDA
Dr Reddy’s Laboratories, one of India’s largest pharmaceutical firms, has revealed that the FDA has given the go-ahead to market …
13 FDA observations on Dr Reddy’s plant send shares to 3 year low
March 9, 2017Manufacturing and Production Dr Reddy's, FDA
Indian pharmaceutical firm Dr Reddy’s has seen its shares drop on the Bombay Stock Exchange to their lowest point in …
India’s NPPA identifies 634 non-compliant drug pricings
February 24, 2017Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa
India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …
India-based Cipla gets new chief financial officer
June 8, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Dr Reddy's, cfo, dr reddys
Cipla (NSE: CIPLA) has poached a top executive from Dr. Reddy’s by naming Kedar Upadhye as its new global chief …
Dr Reddy’s relaunches generic Nexium in blue after AstraZeneca lawsuit
January 6, 2016Manufacturing and Production, Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, acid reflux, esomeprazole, lawsuit, purple pill
Dr Reddy’s has relaunched its generic version of AstraZeneca’s blockbuster heartburn drug Nexium in the US, changing the colour from …
FDA warnings create woe for Indian drugmakers
November 10, 2015Manufacturing and Production CGMP, Dr Reddy's, Dr. Reddy's, FDA, India, Sun Pharma, manufacturing, production
Recent enforcement action has taken its toll on the fortunes of several Indian pharmaceutical manufacturers, with Sun Pharmaceuticals and Dr. …
AZ triumphs in Nexium pay-for-delay trial
December 8, 2014Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole
AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …
Dr Reddy’s recalls blood pressure drug
June 20, 2014Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol
Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
